NEVVI Medicare utilization intelligence
or

← back

Provider profile

TARVER, JERRY M.D.

Anesthesiology · NPI 1235170671 · ABILENE, TX

2
Groups
35
Codes · 2024
4,636
Disclosed services

TARVER, JERRY is a Anesthesiology in ABILENE, TX, a member of 2 medical groups, who billed 35 distinct codes to Medicare Part B in 2024.

Groups: INTEGRATED PAIN ASSOCIATES PLLC (KILLEEN, TX) · THE WEST TEXAS REHABILITATION CENTER (ABILENE, TX) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

4,636
disclosed services
35
codes billed to Medicare Part B
Prior year · CY2023 6,929 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80307 Testing for presence of drug, by chemistry analyzers
J1100 Injection, dexamethasone sodium phosphate, 1 mg
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
64493 Injection of lower or sacral spine facet joint using imaging guidance, single level
64494 Injection of lower or sacral spine facet joint using imaging guidance, second level
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
64635 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint
64636 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance
64491 Injection of upper or middle spine facet joint using imaging guidance, second level
64490 Injection of upper or middle spine facet joint using imaging guidance, single level
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level
64640 Destruction of peripheral nerve or branch
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99153 Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
63650 Insertion of spinal neurostimulator electrode array through skin
76942 Ultrasonic guidance for needle placement
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance
64450 Injection of anesthetic agent and/or steroid into other nerve or branch
77002 Fluoroscopic guidance for needle placement
99152 Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes
64484 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level
64633 Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint
64634 Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint
62321 Injection of substance into middle or upper spine canal using imaging guidance
64555 Insertion of peripheral nerve neurostimulator electrode through skin
80305 Testing for presence of drug, read by direct observation
20610 Aspiration and/or injection of fluid from large joint
64628 Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones
20553 Injection of trigger points, 3 or more muscles
27279 Fusion of pelvic joint using imaging guidance
63685 Insertion or replacement of spinal neurostimulator generator or receiver

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.